DARTS: Depression and Anxiety Reduction Treatment for Suicide

Sponsor
Florida State University (Other)
Overall Status
Completed
CT.gov ID
NCT01941862
Collaborator
United States Department of Defense (U.S. Fed)
300
1
4
46
6.5

Study Details

Study Description

Brief Summary

The purpose of this study is to test the effectiveness and usability of multiple computer-based treatments for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with a variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal ideation, and substance use disorders.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Psychoeducation and Cognitive Bias Modification
N/A

Detailed Description

DARTS is a newly developed computerized treatment targeting specific risk factors associated with suicide, mood, and anxiety symptoms. Eligible individuals will be randomized to one of several conditions. In all conditions, participants will complete various self-report questionnaires and a neurophysiology assessment that involves an EEG. Some participants will also be asked to complete four additional EEG assessments. In addition, all participants will be asked to complete a 1, 3, and 6-month follow-up appointment.

Study Design

Study Type:
Interventional
Actual Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Development and Evaluation of a Brief, Suicide Prevention Intervention Targeting Anxiety and Mood Vulnerabilities
Study Start Date :
Nov 1, 2013
Actual Primary Completion Date :
Sep 1, 2017
Actual Study Completion Date :
Sep 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Anxiety Risk Reduction

The anxiety risk reduction condition will be a combination of psychoeducation plus Cognitive Bias Modification (CBM-I) for anxiety sensitivity (AS). The psychoeducational component will focus on the nature of stress and its effect on the body. Interoceptive exposure (IE) exercises, designed to correct the conditioned fear to these bodily sensations, will be explained and practiced.

Behavioral: Psychoeducation and Cognitive Bias Modification

Experimental: Mood Risk Reduction

The mood risk reduction condition will be a combination of psychoeducation plus Cognitive Bias Modification (CBM-I) for perceived burdensomeness and thwarted belongingness. The psychoeducational component will focus on dispelling myths related to burdensomeness and belongingness and describe their role in the development of mood symptoms.

Behavioral: Psychoeducation and Cognitive Bias Modification

Experimental: Combined Risk Reduction

The combined intervention will involve all of the interventions in the anxiety and mood risk reduction conditions and thus will not be matched for length.

Behavioral: Psychoeducation and Cognitive Bias Modification

No Intervention: Repeated Contact Control

Participants assigned to the repeated contact group will be assigned a "personal" study coordinator. The coordinator will contact them at specific intervals during the study. The rationale for these contacts will be provided (e.g., checking in on their status and helping to administer some brief measures). During the three weeks (corresponding to treatment session intervals for those in one of the active treatment conditions), the study coordinator will contact the participant once per week for a brief phone check in where suicide risk will be evaluated. Participants in the control group will also meet with their study coordinator during each of the scheduled follow-up visits.

Outcome Measures

Primary Outcome Measures

  1. Interpersonal Needs Questionnaire (INQ) [Month 6 follow-up]

    The INQ is a 15-item self-report measure of the constructs of thwarted belongingness and perceived burdensomeness as defined by the Interpersonal Theory of Suicide. Van Orden et al. report high internal consistency coefficients for the thwarted belongingness (α=.85) and perceived burdensomeness subscales (α=.89). In support of construct validity, both subscales were found to prospectively predict suicidal ideation.

Secondary Outcome Measures

  1. Anxiety Sensitivity Index-3 (ASI-3) [Month 6 follow-up]

    The ASI-3 is an 18-item self-report measure of anxiety sensitivity (AS). This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the original ASI provides. Each subfactor is represented by six items. The measure has shown good psychometric properties.

Other Outcome Measures

  1. Beck Suicide Scale (BSS) [Month 6 follow-up]

    The BSS is a 21-item widely used self-report measure assessing a broad spectrum of behaviors and attitudes related to suicide risk, including suicidal ideation and past suicide attempts. It has demonstrated strong reliability and validity.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • At or above community sample mean on ASI-3

  • At or above community sample mean on INQ-R

  • English speakers

  • 18 years of age or older

Exclusion Criteria:
  • Significant medical illness

  • Current substance dependence

  • Current or past psychotic-spectrum disorders

  • Uncontrolled bipolar disorder

  • Serious suicidal intent that warranted immediate treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Florida State University Tallahassee Florida United States 32304

Sponsors and Collaborators

  • Florida State University
  • United States Department of Defense

Investigators

  • Principal Investigator: Norman B Schmidt, Ph.D., Florida State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Norman Schmidt, Professor, Florida State University
ClinicalTrials.gov Identifier:
NCT01941862
Other Study ID Numbers:
  • W81XWH-10-2-0181
First Posted:
Sep 13, 2013
Last Update Posted:
Jun 19, 2018
Last Verified:
Jun 1, 2018

Study Results

No Results Posted as of Jun 19, 2018